Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Dose-Escalated, Intratumoral TLR9 Agonist and Low-Dose Radiation Induce Abscopal Effects in Follicular Lymphoma

Holbrook E Kohrt, MD PhD, Jaqueline Chu, MD, Joshua Brody, MD, Debra K Czerwinski, Cariad Chester, Mohith Sadaram, BS, Ranjana Advani, MD, Youn H. Kim, MD, Richard T. Hoppe, MD, Susan J. Knox, MD PhD, Irene Wapnir, MD, Robert J. Tibshirani, PhD, Ron Levy, MD

Blood (2014) 124 (21): 3092.

https://doi.org/10.1182/blood.V124.21.3092.3092

Published: 2014

Journal Articles

In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study

Youn H. Kim, Dita Gratzinger, Cameron Harrison, Joshua D. Brody, Debra K. Czerwinski, Weiyun Z. Ai, Anjali Morales, Farah Abdulla, Leon Xing, Daniel Navi, Robert J. Tibshirani, Ranjana H. Advani, Bharathi Lingala, Sumit Shah, Richard T. Hoppe, Ronald Levy

Blood (2012) 119 (2): 355–363.

https://doi.org/10.1182/blood-2011-05-355222

Published: 2012

Journal Articles

Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment

Ash A. Alizadeh, Andrew J. Gentles, Alvaro J. Alencar, Chih Long Liu, Holbrook E. Kohrt, Roch Houot, Matthew J. Goldstein, Shuchun Zhao, Yasodha Natkunam, Ranjana H. Advani, Randy D. Gascoyne, Javier Briones, Robert J. Tibshirani, June H. Myklebust, Sylvia K. Plevritis, Izidore S. Lossos, Ronald Levy

Blood (2011) 118 (5): 1350–1358.

https://doi.org/10.1182/blood-2011-03-345272

Published: 2011

Includes: Supplemental data

Journal Articles

In Situ Vaccination with TLR9 Agonist Combined with Local Radiation In Mycosis Fungoides: Analysis of Phase I/II Study

Youn H. Kim, MD, Dita Gratzinger, MD, PhD, Cameron Harrison, MD, Joshua Brody, MD, Debra Czerwinski, Leon Xing, Anjali Morales, MD, PhD, Weiyun Ai, MD, PhD, Farah Abdulla, MD, Daniel Navi, MD, Robert J. Tibshirani, PhD, Ranjana Advani, MD, Yasodha Natkunam, MD, PhD, Richard T. Hoppe, MD, Ron Levy, MD

Blood (2010) 116 (21): 286.

https://doi.org/10.1182/blood.V116.21.286.286

Published: 2010

Journal Articles

Prediction of Survival In Diffuse Large B-Cell Lymphoma Based On the Expression of Two Genes Reflecting Tumor and Microenvironment

Ash A. Alizadeh, MD/PhD, Andrew J. Gentles, Ph.D., Alvaro J. Alencar, MD, Holbrook E Kohrt, MD, Roch Houot, MD/PhD, Matthew J Goldstein, BA, Shuchun Zhao, Ph.D., Yasodha Natkunam, MD, PhD, Ranjana Advani, MD, Randy D. Gascoyne, MD, Javier Briones, MD, Robert J. Tibshirani, Ph.D., June Helen Myklebust, PhD, Sylvia K. Plevritis, PhD, Izidore S Lossos, MD, Ronald Levy, MD

Blood (2010) 116 (21): 2006.

https://doi.org/10.1182/blood.V116.21.2006.2006

Published: 2010

Journal Articles

Prognostic Significance of VEGF, VEGF Receptors, and Microvessel Density in Diffuse Large B Cell Lymphoma Treated with Anthracycline-Based Chemotherapy.

Dita Gratzinger, MD, PhD, Shuchun Zhao, MS, Robert J. Tibshirani, PhD, Eric D. Hsi, MD, Christine P. Hans, MD, Brad Pohlman, MD, Martin Bast, Abraham Avigdor, MD, Ginette Schiby, MD, Arnon Nagler, Gerald E. Byrne, MD, Izidore S. Lossos, MD, Yasodha Natkunam, MD, PhD

Blood (2007) 110 (11): 53.

https://doi.org/10.1182/blood.V110.11.53.53

Published: 2007

NARROW

Dose-Escalated, Intratumoral TLR9 Agonist and Low-Dose Radiation Induce Abscopal Effects in Follicular Lymphoma

In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study

Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment

In Situ Vaccination with TLR9 Agonist Combined with Local Radiation In Mycosis Fungoides: Analysis of Phase I/II Study

Prediction of Survival In Diffuse Large B-Cell Lymphoma Based On the Expression of Two Genes Reflecting Tumor and Microenvironment

Prognostic Significance of VEGF, VEGF Receptors, and Microvessel Density in Diffuse Large B Cell Lymphoma Treated with Anthracycline-Based Chemotherapy.

Email alerts

ASH Publications

American Society of Hematology

Dose-Escalated, Intratumoral TLR9 Agonist and Low-Dose Radiation Induce Abscopal Effects in Follicular Lymphoma

In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study

Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment

In Situ Vaccination with TLR9 Agonist Combined with Local Radiation In Mycosis Fungoides: Analysis of Phase I/II Study

Prediction of Survival In Diffuse Large B-Cell Lymphoma Based On the Expression of Two Genes Reflecting Tumor and Microenvironment

Prognostic Significance of VEGF, VEGF Receptors, and Microvessel Density in Diffuse Large B Cell Lymphoma Treated with Anthracycline-Based Chemotherapy.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only